Unichem Laboratories Ltd Falls 7.75%: 6 Key Factors Driving the Weekly Decline

13 July 2026: Upgrade to Hold Amid Technical Improvements

Unichem Laboratories Ltd began the week with an upgrade from 'Sell' to 'Hold' by MarketsMOJO, reflecting improved technical indicators and a recalibrated valuation. Despite the stock closing lower at Rs.597.10, down 6.63% from the previous close, the upgrade was driven by bullish momentum signals such as a positive weekly MACD and supportive Bollinger Bands. The stock traded within a wide intraday range of Rs.632.00 to Rs.672.00, indicating volatility but underlying support above its 52-week low of Rs.280.00.

Valuation metrics showed a fair but premium stance, with a PE ratio of 64.21 and EV/EBITDA of 25.99, higher than many sector peers. Financially, the company reported a 52.9% decline in profit before tax for Q4 FY25-26, highlighting margin pressures despite strong long-term operating profit growth of 52.68% CAGR. The upgrade suggested cautious optimism, balancing technical strength against fundamental challenges.

14 July 2026: Downgrade to Sell Following Mixed Technicals and Weak Financials

The positive sentiment was short-lived as MarketsMOJO downgraded Unichem Laboratories back to 'Sell' on 14 July, citing deteriorating technical indicators and disappointing quarterly financial results. The stock closed at Rs.582.30, down 2.48% on the day, reflecting investor caution. The downgrade was influenced by a sharp 52.9% drop in Q4 profit before tax and a 31.1% fall in net profit after tax, alongside a low debt-to-equity ratio of 0.06 times indicating limited leverage risk.

Technically, the trend shifted from bullish to mildly bullish, with weekly MACD remaining positive but monthly MACD turning bearish. The Relative Strength Index (RSI) was bearish on the weekly scale, signalling weakening momentum. Despite these negatives, the stock had outperformed the Sensex over longer periods, with a 31.94% year-to-date gain versus the Sensex’s 9.58% decline, underscoring some resilience amid sector headwinds.

15 July 2026: Mixed Technical Momentum Amid Price Volatility

On 15 July, Unichem Laboratories’ technical momentum showed signs of transition from bullish to mildly bullish, reflecting a complex market outlook. The stock closed at Rs.582.30, down 2.48%, with intraday volatility between Rs.576.50 and Rs.620.35. The weekly MACD remained bullish but monthly MACD was bearish, while the RSI was bearish weekly and neutral monthly, indicating short-term weakness but uncertain longer-term momentum.

Despite the downgrade and mixed signals, the stock continued to outperform the Sensex over multiple timeframes, including a 31.94% year-to-date return versus the Sensex’s 9.58% decline. The company’s small-cap status and sector volatility contributed to the nuanced technical picture, with daily moving averages still supporting a positive short-term trend.

16 July 2026: Strong Gap Up Signals Short-Term Bullishness

Unichem Laboratories opened 5.06% higher on 16 July, marking a significant gap up to Rs.625 from the previous close. The stock closed at Rs.594.90, up 2.16% on the day, outperforming the Sensex’s 0.36% gain. This gap up reflected renewed investor interest and positive momentum, supported by the stock trading above all key moving averages (5-day to 200-day).

Technical indicators showed a bullish weekly MACD and mildly bullish monthly MACD, though the RSI remained bearish weekly, signalling some short-term caution. Bollinger Bands were mildly bullish weekly and bullish monthly, suggesting expanding volatility aligned with upward price movement. The stock’s adjusted beta of 1.35 indicated higher volatility relative to the small-cap market, consistent with the pronounced price swings observed.

17 July 2026: Week Ends Lower Amid Profit Taking

The week concluded with Unichem Laboratories closing at Rs.589.95, down 2.50% on 17 July. This decline capped a week of volatility and mixed signals, with the stock ending below its opening price of Rs.639.50 on 13 July. Technical momentum remained cautiously bullish, with daily moving averages supporting the price but weekly RSI indicating potential short-term overbought conditions.

The Sensex closed nearly flat at 36,505.40, underscoring Unichem’s relative underperformance during the week. Investors faced a complex environment balancing the company’s strong long-term returns against recent financial softness and technical uncertainty.

Key Takeaways

Positive Signals: Despite the weekly decline, Unichem Laboratories demonstrated strong long-term returns, outperforming the Sensex over one month, year-to-date, and five-year periods. Technical momentum showed intermittent bullish shifts, with daily moving averages and weekly MACD supporting short-term strength. The significant gap up on 16 July highlighted renewed investor interest and potential for price recovery.

Cautionary Signals: The week was dominated by mixed and deteriorating technical indicators, including bearish weekly RSI and bearish monthly MACD, signalling potential short-term weakness. The downgrade to a Sell rating reflected concerns over weak quarterly financials, including a 52.9% drop in profit before tax and rising interest expenses. The stock’s high beta of 1.35 suggests elevated volatility, increasing risk for investors amid uncertain momentum.

Conclusion

Unichem Laboratories Ltd’s week was characterised by volatility and mixed signals, with the stock falling 7.75% against a flat Sensex. The initial upgrade to Hold was quickly reversed amid disappointing financial results and weakening technical momentum, culminating in a Sell rating. However, the strong gap up midweek and supportive daily moving averages indicate that short-term bullish momentum remains possible. Investors should weigh the company’s solid long-term performance against recent fundamental and technical challenges, remaining cautious amid the stock’s elevated volatility and uncertain near-term outlook.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today